Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/1999
07/01/1999WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use
07/01/1999WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
07/01/1999WO1999032456A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
07/01/1999WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
07/01/1999WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
07/01/1999WO1999032449A2 Benzazine derivatives as phosphodiesterase 4 inhibitors
07/01/1999WO1999032125A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
07/01/1999WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
07/01/1999WO1999032110A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
07/01/1999WO1999032089A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
07/01/1999WO1999032082A2 Pharmaceutical compositions
07/01/1999WO1999016741A3 Lipophilic diesters of chelating agents
07/01/1999CA2315782A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
07/01/1999CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas
07/01/1999CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use
07/01/1999CA2313163A1 Pharmaceutical compositions
06/1999
06/30/1999EP0926137A1 Picolin acid derivatives useful in the treatment of IL-1 and TNF mediated diseases
06/30/1999EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof
06/30/1999EP0925287A1 Heterocyclic metalloprotease inhibitors
06/30/1999EP0749429B1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
06/30/1999CN1221407A Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
06/30/1999CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function
06/30/1999CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof
06/30/1999CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof
06/30/1999CA2256002A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives
06/29/1999US5917014 Methods of treating inflammation and compositions therefor
06/29/1999US5916922 For inhibiting human non-pancreatic secretory phospholipase a2
06/29/1999US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
06/29/1999US5916590 Soft gelatin pharmaceutical dosage form
06/29/1999CA2097823C Therapy for pulmonary vasoconstriction and asthma
06/29/1999CA1340611C Recombinant alveolar surfactant protein
06/24/1999WO1999031232A1 Human brain derived kcnq2 potassium channel
06/24/1999WO1999031105A1 3-substituted adenines via2-thioxanthines
06/24/1999WO1999031104A1 Preparation of 3-substituted adenines and imidazo pyridines
06/24/1999WO1999031103A1 Preparation of 3-substituted adenines
06/24/1999WO1999031102A1 Purine derivatives having phosphodiesterase iv inhibition activity
06/24/1999WO1999031090A1 Dihydrobenzofurans
06/24/1999WO1999031059A1 Potassium channel openers
06/24/1999WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression
06/24/1999WO1999030714A1 Sustained-release theophylline preparation and process for producing the same
06/24/1999WO1999030703A1 Use of formoterol in medicament for inflammation/allergy in upper airways
06/24/1999WO1999030695A1 Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease
06/24/1999WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
06/24/1999WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
06/24/1999WO1999005155A3 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
06/24/1999DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc.
06/24/1999CA2314948A1 Potassium channel openers
06/24/1999CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression
06/24/1999CA2314885A1 Pharmaceutical compositions for mucolysis and treatment of inflammation
06/24/1999CA2314395A1 Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease
06/24/1999CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity
06/24/1999CA2314111A1 Dihydrobenzofurans
06/24/1999CA2313004A1 3-substituted adenines via2-thioxanthines
06/23/1999EP0924201A1 Tricyclic-substituted pyrazolyl benzenesulfonamides and their use as cyclooxygenase II inhibitors
06/23/1999EP0923933A1 Substituted pyrazolyl benzenesulfonamides for use in the treatment of inflammation
06/23/1999EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives
06/23/1999EP0923568A1 Novel benzofuran-4-carboxamides
06/23/1999EP0923563A1 1,4-heterocyclic metallprotease inhibitors
06/23/1999EP0923561A1 Heterocyclic metalloprotease inhibitors
06/23/1999EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
06/23/1999EP0923546A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
06/23/1999EP0923376A1 Treatment of asthma and airway diseases
06/23/1999EP0923373A1 Il-8 receptor antagonists
06/23/1999EP0923370A2 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
06/23/1999CN1043761C Fluorinated hydroxyalkylquinoline acid and medicinal salt and its drug composition
06/22/1999US5914352 Methods for the use of stabilized fluorocarbon emulsions
06/22/1999US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue
06/17/1999WO1999029726A1 Phospholipase inhibitor
06/17/1999WO1999029695A1 Novel compounds
06/17/1999WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999WO1999029685A1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2-[(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt
06/17/1999WO1999029339A2 Prevention and/or treatment of allergic conditions
06/17/1999WO1999029296A1 Pharmaceutical aerosol compositions
06/17/1999WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/17/1999WO1999016420A9 Stabilized preparations for use in nebulizers
06/17/1999WO1999013064A3 Viral infection of cells using viral vectors
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312965A1 (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chlorophenyl|-1h-pyrazol-4-yl|-2-¬(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl|-prop-2-enoic acid monoargininyl salt
06/17/1999CA2312419A1 Novel compounds
06/16/1999EP0922697A1 Substituted Pyrazolyl benzenesulfonamides and their use as cyclooxygenase II inhibitors
06/16/1999EP0922453A2 Percutaneous absorption type preparation containing tulobuterol
06/16/1999EP0922036A1 Arylalkanoyl pyridazines
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921809A1 Use of prolactin as a tgf-beta antagonist
06/16/1999EP0921807A1 Hydrogenous medicament
06/16/1999EP0921795A1 An aqueous formulation comprising bambuterol and the use thereof
06/16/1999EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
06/16/1999EP0528922B1 New sulfonyl compounds
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219535A Process for preparing leukotrienes antagonist
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
06/15/1999US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease
06/15/1999US5912270 Anti-inflammatory compounds
06/15/1999US5912251 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/15/1999US5912244 Muscle disorders, breathing disorders and urinary incontinence
06/15/1999US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents
06/15/1999US5911988 Method for treating asthma using SCF antibody
1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 878